In addition, higher levels of expression of GDF11 were noted in low-risk MDS patients compared to healthy controls [19], while GDF11 levels were negatively correlated with hemoglobin levels in low-risk MDS patients and with late-stage erythroblasts and RBC levels in high-risk MDS patients [20]. Here, GDF11 is linked to myelodysplastic syndrome.